In this study, we demonstrated that high serum Ca and high PTHLH expression in tumors, the major etiology of hypercalcemia in malignancy, were observed in clear cell RCCs but not in other non clear cell tumors when using the 2004 WHO renal tumor classification. This evidence concerns the gene PTHLH and hypercalcemia disease.